ZIND Verfahrenstechnik products

At pilot stage, the primary membrane candidate has been chosen, as process parameters. Typically at this stage, the production method is being verified and production materials produced for toxicology or pre-clinical trials and predictable scalability is imperative. In order to facilitate the manufacturing life cycle of a successful therapeutic candidate, cGMP manufacturing needs to begin at relatively small scale to facilitate human clinical trials. Manufacturing material for this early pilot scale manufacturing can easily and effectively be accomplished using the TangenX NovaSet UF and MF cassettes. Like the corresponding NovaSet-LS process development membrane cassettes, NovaSet pilot and process scale cassettes are available in a comprehensive range of options that are directly scalable from earlier development using the NovaSet cassettes.

The manufacture of products in the pharmaceutical industry is a very sensitive area that places the highest demands on suppliers in the areas of knowledge, materials and quality management. Of particular importance is the transparency of products that are produced and delivered with certificates, credentials and lot numbers, sterilised or unsterilised, according to international guidelines. ZIND Verfahrenstechnik stands up to these challenges and, as a competent partner that operates multi-nationally, offers a portfolio that meets the demands of the pharmaceutical industry, as can be seen in the outline of product categories below: